Panagis Galiatsatos, M.D., MHS

Panagis Galiatsatos, M.D., MHS

National Spokesperson

Assistant Professor, Johns Hopkins School of Medicine and Community Engagement Co-Director, Baltimore Breathe Center

Areas of Expertise:
Pulmonology, tobacco cessation, public health, youth vaping

Panagis Galiatsatos, M.D., MHS completed his undergraduate studies at Temple University and his medical degree at the University of Maryland School of Medicine. He completed his residency at the Johns Hopkins Bayview Medical Center in internal medicine, where he also served as an assistant chief of service. Then, he went into pulmonary and critical care training at the National Institutes of Health in Bethesda and at the Johns Hopkins Hospital in Baltimore City. He also earned a masters in health sciences degree from Duke University School of Medicine and a masters as a tobacco treatment specialist from the University of Pennsylvania.

He is an Assistant Professor at the Johns Hopkins School of Medicine where he currently co-directs Medicine for the Greater Good (MGG) and is the community engagement co-director for the Baltimore Breathe Center. Through his work in Baltimore City, he has been able to tackle community health needs through collaborations and partnerships, implementing population health strategies, and creating educational programs for healthcare professionals to become physician citizens. His projects have impacted over 7,000 Baltimore City persons and over 150 healthcare professional learners.

Currently, his research interests are in chronic obstructive pulmonary disease, asthma, tobacco dependence, and health equity. He co-authored a book, "Building Healthy Community Partnerships Through Medical Religious Partnerships" that captures much of the projects he has implemented and overseen. He is the son of Greek immigrant parents and was born and raised in Baltimore.

Media interested in scheduling an interview with Dr. Galiatsatos may contact Media@Lung.org.

Page last updated: April 20, 2024

Lung Cancer Biomarker Testing
, | Nov 16, 2024